Professor, Medicine, University of Colorado School of Medicine
Cardiology
Dr. Luisa Mestroni, MD
|
|
Give Review
Dr. Luisa Mestroni is an expert in the field of Cardiology. He over the years received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACC)". Doctor Luisa Mestroni, MD is a published doctor. He published 98 publications, including: 'Advances in molecular genetics of dilated cardiomyopathy. The Heart Muscle Disease Study Group.' Luisa Mestroni is registered with Medicare and accepts Medicare payments.
Publications
- Analysis of long- and short-range contribution to adhesion work in cardiac fibroblasts: An atomic force microscopy study.
- GENETIC CAUSES OF DILATED Cardiomyopathy.
- Carbon nanotube facilitation of Myocardial ablation with radiofrequency energy.
- Decreased levels of BAG3 in a family with a rare variant and in idiopathic dilated Cardiomyopathy.
- Titin and desmosomal genes in the natural history of arrhythmogenic right ventricular Cardiomyopathy.
- Danon Disease: clinical features, evaluation, and management.
- Family Members of Patients With ARVC: Who Is at Risk? At What Age? When and How Often Should We Evaluate to Determine Risk?
- Pharmacogenetics of Heart failure.
- Inhibition of Proto-Oncogene c-Src Tyrosine Kinase: Toward a New Antiarrhythmic Strategy?
- Poor Prognosis of Rare Sarcomeric Gene Variants in Patients with Dilated Cardiomyopathy.
- Genetics and genetic testing of dilated Cardiomyopathy: a new perspective.
- Utility of Cardiac Magnetic Resonance Imaging to Differentiate Cardiac Sarcoidosis from Arrhythmogenic Right Ventricular Cardiomyopathy.
- Role of Titin Missense Variants in Dilated Cardiomyopathy.
- Whole exome sequencing identifies a troponin T mutation hot spot in familial dilated Cardiomyopathy.
- Current perspective new insights into the molecular basis of familial dilated Cardiomyopathy.
- Lamin A/C gene mutation associated with dilated Cardiomyopathy with variable skeletal muscle involvement.
- [Classification of cardiomyopathies].
- Familial dilated cardiomyopathy: evidence for genetic and phenotypic heterogeneity. Heart Muscle Disease Study Group.
- Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprolol. The Heart-Muscle Disease ...
- Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Card...
- Advances in molecular genetics of dilated cardiomyopathy. The Heart Muscle Disease Study Group.
- [The classification of cardiomyopathies].
- Dystrophin gene abnormalities in two patients with idiopathic dilated Cardiomyopathy.
- Molecular genetics of dilated Cardiomyopathy.
- Dilated Cardiomyopathy: a genetic approach.
- Genetic factors in dilated Cardiomyopathy.
- A new locus for arrhythmogenic right ventricular dysplasia on the long arm of chromosome 14.
- A point mutation in the 5'' splice site of the dystrophin gene first intron responsible for X-linked dilated Cardiomyopathy.
- [Genetics of dilated cardiomyopathies].
- Molecular genetics of dilated cardiomyopathies.
- [The classification of cardiomyopathies: is a revision opportune?].
- Nested polymerase chain reaction for high-sensitivity detection of enteroviral RNA in biological samples.
- Parental origin of the X chromosome in a patient with a Robertsonian translocation and Turner''s Syndrome.
- Idiopathic left ventricular Aneurysm: a clinical and pathological study of a new entity in the spectrum of cardiomyopathies.
- Low frequency of detection by nested polymerase chain reaction of enterovirus ribonucleic acid in endoMyocardial tissue of patients with idiopathic dilated cardiomyopa...
- Evidence from family studies for autoimmunity in dilated Cardiomyopathy.
- Familial dilated Cardiomyopathy.
- Absence of linkage between idiopathic dilated Cardiomyopathy and candidate genes involved in the immune function in a large Italian pedigree.
- A mutation in the dystrophin gene selectively affecting dystrophin expression in the Heart.
- Linkage of familial dilated cardiomyopathy to chromosome 9. Heart Muscle Disease Study Group.
- Ventricular Arrhythmias in congestive cardiomyopathy.
- Vasodilators in left ventricular Failure.
- [Captopril therapy in chronic congestive Heart failure].
- [Retrospective study of coxsackie B virus infections and congestive Cardiomyopathy].
- [Protocol-guide in clinical experimentation on vasodilator agents in Chronic cardiac failure].
- [Dilated Cardiomyopathy: etiopathogenesis].
- Ventricular Arrhythmias in dilated cardiomyopathy: efficacy of amiodarone.
- Arrhythmias in dilated cardiomyopathy.
- [The electrocardiogram in dilated Cardiomyopathy].
- [Ambulatory ECG in cardiomyopathies].
- [Cardiac amyloidosis. Invasive and noninvasive diagnosis].
- [Vasodilators: which, how, when].
- [Calcium antagonists in congestive Heart failure].
- Correlation between histomorphometric findings on endomyocardial biopsy and clinical findings in idiopathic dilated Cardiomyopathy.
- Clinical and pathologic study of familial dilated Cardiomyopathy.
- [The prognostic assessment of dilated Cardiomyopathy: a follow-up of 138 patients].
- Clinical aspects and haemodynamics in the follow-up of dilated Cardiomyopathy and myocarditis.
- [The pathogenesis of dilated Cardiomyopathy: current progress].
- [Beta blocking agents in the treatment of dilated Cardiomyopathy: review of the literature and clinical experience with 67 patients].
- Beta-adrenergic neuroeffector abnormalities in the failing human Heart are produced by local rather than systemic mechanisms.
- Dilated Cardiomyopathy and muscular dystrophies: which lesson can be learned?
- [Dilated Cardiomyopathy: role of clinical and instrumental evaluation of the neuromuscular system].
- [Dilated Cardiomyopathy: etiology, clinical criteria for diagnosis and screening of the familial form].
- Truncations of titin causing dilated Cardiomyopathy.
- Sudden death associated with danon Disease in women.
- High-throughput genotyping robot-assisted method for mutation detection in patients with hypertrophic Cardiomyopathy.
- Genetic variation in titin in arrhythmogenic right ventricular Cardiomyopathy-overlap syndromes.
- Pharmacogenomics, personalized medicine, and Heart failure.
- Hearing the noise the challenges of human genome variation in genetic testing.
- SCN5A mutations associate with arrhythmic dilated Cardiomyopathy and commonly localize to the voltage-sensing mechanism.
- Prognostic predictors in arrhythmogenic right ventricular Cardiomyopathy: results from a 10-year registry.
- Heart failure and personalized medicine.
- Prognostic impact of familial screening in dilated Cardiomyopathy.
- Phenotypic heterogeneity of sarcomeric gene mutations: a matter of gain and loss?
- Genetic evaluation of cardiomyopathy--a Heart Failure Society of America practice guideline.
- Pharmacogenetic effect of an endothelin-1 haplotype on response to bucindolol therapy in chronic Heart failure.
- Lamin A/C gene and the Heart: how genetics may impact clinical care.
- The challenge of cardiomyopathies in 2007.
- Cardiomyopathy and carnitine deficiency.
- Are nonsustained ventricular tachycardias predictive of major Arrhythmias in patients with dilated cardiomyopathy on optimal medical treatment?
- Danon Disease presenting with dilated cardiomyopathy and a complex phenotype.
- Prevalence of desmin mutations in dilated Cardiomyopathy.
- Cardiomyopathy, familial dilated.
- Ophthalmic manifestations of Danon Disease.
- Thymopoietin (lamina-associated polypeptide 2) gene mutation associated with dilated Cardiomyopathy.
- Alpha-myosin heavy chain: a sarcomeric gene associated with dilated and hypertrophic phenotypes of Cardiomyopathy.
- Drug therapy in the Heart transplant recipient: part II: immunosuppressive drugs.
- Drug therapy in the Heart transplant recipient: part I: cardiac rejection and immunosuppressive drugs.
- Analysis of genetic variations of lamin A/C gene (LMNA) by denaturing high-performance liquid chromatography.
- SCN5A mutation associated with dilated Cardiomyopathy, conduction disorder, and arrhythmia.
- [The natural history of dilated cardiomyopathy: a review of the Heart Muscle Disease Registry of Trieste].
- [How the natural history of dilated cardiomyopathy has changed. Review of the Registry of Myocardial Diseases of Trieste].
- Familial hypertrophic Cardiomyopathy: clinical features, molecular genetics and molecular genetic testing.
- Cardiology patient page. Familial dilated Cardiomyopathy.
- Genomic medicine and Atrial fibrillation.
- Natural history of dilated Cardiomyopathy due to lamin A/C gene mutations.
- Pediatric Cardiomyopathy: New Insight Into Potential Disease Mechanisms.
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac Myocardial Perfusion Imaging
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Aortic Aneurysm
- Aortic Valve Disease
- Arrhythmias (incl. Atrial Fibrillation)
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- American Republic
- Pathway X Bronze Direct CACA IN HIX
- Anthem Blue Cross Blue Shield PPO
- Assurant Health
- Blue Card PPO
- Great West Healthcare-Cigna PPO
- Cofinity PPO
- Commercial Insurance Company
- CoreSource
- Coventry Health Care
- First Health (Coventry Health Care) PPO
- Golden Rule
- Humana
- Medicaid
- Medical Mutual of Ohio
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- National Elevator
- POMCO Group
- Thrivent Financial
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACC)
Hospital
-
University of Colorado Hospital
Drug Facts
| NPI NUMBER | 1871683557 | |
| NPPES Provider LastName | MESTRONI | |
| NPPES Provider FirstName | LUISA | |
| NPPES Provider ZIPCode | 800452545 | |
| NPPES Provider State | CO | |
| Specialty Description | Cardiology | |
| Total Claim Count | 178.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1871683557 |
| Last Name Of The Provider | MESTRONI |
| First Name Of The Provider | LUISA |
| View All |
Similar Doctors
|
|
Dr. Eugenia P. Carroll, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christine M. Tompkins, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andreas Brieke, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Michael Bristow, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Karl Hammermeister, MD |
|
Dr. Jonathan A. Sherman, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Brian Stauffer, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Lawrence J. Hergott, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lawrence D. Horwitz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Philip B. Dattilo III, MD
This Doctor is OpenDoctor Recommended.
|